Medical Properties Trust Stock Price To Earnings To Growth
M3P Stock | EUR 3.68 0.06 1.66% |
Medical Properties Trust fundamentals help investors to digest information that contributes to Medical Properties' financial success or failures. It also enables traders to predict the movement of Medical Stock. The fundamental analysis module provides a way to measure Medical Properties' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medical Properties stock.
Medical |
Medical Properties Trust Company Price To Earnings To Growth Analysis
Medical Properties' PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
Competition |
Based on the latest financial disclosure, Medical Properties Trust has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Real Estate sector and 100.0% lower than that of the REIT - Healthcare Facilities industry. The price to earnings to growth for all Germany stocks is 100.0% higher than that of the company.
Medical Price To Earnings To Growth Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medical Properties' direct or indirect competition against its Price To Earnings To Growth to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medical Properties could also be used in its relative valuation, which is a method of valuing Medical Properties by comparing valuation metrics of similar companies.Medical Properties is currently under evaluation in price to earnings to growth category among its peers.
Medical Fundamentals
Return On Equity | 0.11 | |||
Return On Asset | 0.0325 | |||
Profit Margin | 0.57 % | |||
Operating Margin | 0.66 % | |||
Current Valuation | 15.57 B | |||
Shares Outstanding | 597.48 M | |||
Shares Owned By Insiders | 1.28 % | |||
Shares Owned By Institutions | 84.90 % | |||
Price To Earning | 5.91 X | |||
Price To Book | 0.80 X | |||
Price To Sales | 4.22 X | |||
Revenue | 1.54 B | |||
Gross Profit | 1.54 B | |||
EBITDA | 1.34 B | |||
Net Income | 902.6 M | |||
Cash And Equivalents | 995.55 M | |||
Cash Per Share | 2.52 X | |||
Total Debt | 10.27 B | |||
Debt To Equity | 83.90 % | |||
Current Ratio | 12.27 X | |||
Book Value Per Share | 14.38 X | |||
Cash Flow From Operations | 811.66 M | |||
Earnings Per Share | 1.41 X | |||
Target Price | 23.42 | |||
Number Of Employees | 21 | |||
Beta | 0.97 | |||
Market Capitalization | 5.99 B | |||
Total Asset | 19.66 B | |||
Annual Yield | 0.11 % | |||
Five Year Return | 6.05 % | |||
Net Asset | 19.66 B | |||
Last Dividend Paid | 1.16 |
About Medical Properties Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medical Properties Trust's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medical Properties using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medical Properties Trust based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Medical Stock
When determining whether Medical Properties Trust is a strong investment it is important to analyze Medical Properties' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Medical Properties' future performance. For an informed investment choice regarding Medical Stock, refer to the following important reports:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medical Properties Trust. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.